Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > This will probably get bought out buy a big pharma company
View:
Post by Bigginvestor on Apr 14, 2021 6:43pm

This will probably get bought out buy a big pharma company

this will get bought out buy a big pharma company . hold tight and long can't wait $$$$$
Comment by 011Peking on Apr 14, 2021 8:37pm
What could then be the predictable buyout price you think?  Sa we're at 0.1$/share when we get bought out or whatever it's called. Would they have to buy it for x10 or x what? Or at the price that is? does anybody know how a buyout works for us shareholders! Good or bad?
Comment by millritemike on Apr 14, 2021 8:51pm
Let's hope they don't get bought out. If big pharmaceutical offers an increase of .075 cents is 100% of current price. 15 cents can take it all and current holders can't do a thing about it. Look what happened to Perigrine Diamonds. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities